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Objectives:
 
 We analyzed the association of left ventricular end-systolic
diameter (LVESD) with survival after diagnosis in organic mitral regurgitation
(MR) due to flail leaflets.
 
Background: 
 
LVESD is a marker of left ventricular function in patients
with organic MR but its association to survival after diagnosis is unknown.
 
Methods: 
 
The Mitral regurgitation International DAtabase (MIDA) is a mul-
ticenter registry of echocardiographically-diagnosed organic MR due to flail
leaflets. We enrolled 739 patients with MR due to flail leaflets (65±12 years;
ejection fraction [EF] 65±10%) in whom LVESD was measured (36±7mm).
 
Results:
 
 Under conservative management, 10-year survival and survival
free of cardiac death were higher with LVESD <40mm vs. 
 
≥
 
40mm (64±5%
vs. 48±10%; p<0.001, and 73±5% vs. 63±10%; p=0.001). LVESD 
 
≥
 
40mm
independently predicted overall mortality (HR 1.95[1.01-3.83]) and cardiac
mortality (HR 3.09[1.35-7.09]) under conservative management. Mortality risk
increased linearly with LVESD above 40mm (HR 1.15[1.04-1.27] per 1mm
increment). There was no interaction between presence of symptoms or
EF<60% and LVESD impact on survival (p=0.69). During the entire follow-
up (including post-surgical), LVESD 
 
≥
 
40mm independently predicted overall
mortality (HR 1.86[1.24-2.80]) and cardiac mortality (HR 2.14[1.29-3.56]),
due to persistence of excess mortality in patients with LVESD 
 
≥
 
40mm after
surgery (HR 1.86[1.11-3.15] for overall death, and 1.81[1.05-3.54] for cardiac
death).
 
Conclusions: 
 
In MR due to flail leaflets, LVESD 
 
≥
 
40mm is independently
associated with increased mortality under medical management, but also after
mitral surgery. These findings support prompt surgical rescue in patients with
LVESD 
 
≥
 
40mm but also suggest that best preservation of survival is achieved
in patients operated before LVESD reaches 40mm.
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Background:
 
 Abnormal exercise test defined as the occurrence of exercise
limiting symptoms, fall in blood pressure below baseline, or complex ventric-
ular arrhythmias is useful to predict clinical events in asymptomatic patients
with aortic stenosis (AS). Whether exercise stress echocardiography (ESE)
provides incremental prognostic information beyond that obtained from stan-
dard exercise testing remains uncertain.
 
Objective:
 
 This study aimed at determine if ESE adds any incremental pre-
dictive value to resting echocardiography in the subset of patients who have a
normal exercise response.
 
Methods:
 
 In this multicenter prospective study, 186 asymptomatic patients
with at least moderate AS and preserved LV ejection fraction (LVEF
 
≥
 
50%)
 
were assessed by Doppler-echocardiography at rest and during a maximum
ramp semi-supine bicycle exercise test.
 
Results:
 
 Fifty one (27%) patients had an abnormal exercise test and
were excluded from the present analysis. Among the 135 patients with
normal exercise test, 65 had an event (aortic valve replacement or cardio-
vascular death) at a mean follow-up of 13±11 months. The independent pre-
dictors of events were: LV hypertrophy (hazard ratio [HR] = 2.49; 95%
confidence interval [CI]: 1.46-4.31; P = 0.0008), resting mean gradient > 35
mmHg (HR = 3.39; 95%CI: 2.00-5.93; P <0.0001) and exercise-induced
increase in mean gradient > 20 mmHg (HR = 2.35; 95%CI: 1.29-4.17; P =
0.005). The latter factor also remained an independent predictor (HR =
2.39; 95%CI: 1.28-4.35; P = 0.007) of events in the subset of patients with
severe AS.
 
Conclusion:
 
 The exercise-induced increase in transvalvular gradient may
be helpful to improve risk stratification in asymptomatic AS patients with
normal exercise response. These results thus suggest that ESE provides addi-
tional prognostic information over that obtained from standard exercise testing
and resting echocardiography.
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Background:
 
 We sought to determine thresholds of aortic valvular calcifi-
cation (AVC) for the diagnosis of severe aortic stenosis (AS) using multislice
computed tomography (MSCT) and to test their accuracy in patients with
reduced ejection fraction (EF).
 
Methods: 
 
161 patients with AS underwent within 1 month TTE and
MSCT. Severe AS was defined on valve area (AVAi 
 
≤
 
0.6cm
 
2
 
/m
 
2
 
), mean
gradient (MG
 
≥
 
 40 mm Hg) and stress echocardiography and surgical find-
ings in patients with reduced EF. Our population was divided into 2 sub-
sets. Validation set (140 patients with EF>40%): to evaluate the
relationship between hemodynamic severity and AVC. Testing set
(21 patients with EF
 
≤
 
 40%): to evaluate the accuracy of AVC thresholds
for the diagnosis of severe AS.
 
Results: 
 
Validation set: Mean EF was 61±6%, AVAi 0.66±0.24cm
 
2
 
/m
 
2
 
 and
AVC score 1926±1687AU. AS was severe in 63 patients (45%) and non-severe
in 77 (55%). Association between AVC and AVAi was curvilinear (r= 0.66,
 
P
 
<0.0001) and a score 
 
≥
 
1651AU provided 79% sensitivity and 86% specificity
for diagnosis of severe AS. A threshold of 700AU provided high sensitivity
(98%) and NPV (97%) whereas a threshold of 2000 AU provided high speci-
ficity (94%) and good PPV (89%). Testing set: Mean EF was 29±9%, AVAi
0.46±0.15cm
 
2
 
/m
 
2
 
 and AVC score 3268±1930AU. Among these 21 patients, 8
had a low-gradient/low-output (AVAi 
 
≤
 
0.6cm
 
2
 
/m
 
2
 
 and MG<40 mmHg). Overall,
AS was non-severe in 5 patients and severe in 16. All but one was correctly clas-
sified using the threshold of 1651 AU (93% sensitivity, 100% specificity,
100%VPP and 83%VPN). Only one patient with a severe AS (AVAi=0.53 cm
 
2
 
/
m
 
2
 
) and a borderline AVC score (1436 AU) was misclassified.
 
Conclusions: 
 
In this large series of patients with a wide range of AS, we
show that 1) hemodynamic severity and AVC quantitatively assessed using
MSCT are strongly correlated and 2) we provide useful thresholds for the eval-
uation of AS severity for difficult cases, in particular patients with reduced EF.
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